Artificial intelligence-enhanced wearable devices, such as continuous glucose monitors (CGMs), have dramatically improved the ability of people with diabetes and even prediabetes to better understand and control their blood ...
Dec 8, 2025
0
0
More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune disorder that can cause life-threatening ...
Dec 9, 2025
0
49
Glioblastoma is the most common form of brain cancer in adults, and its consequences are usually quick and fatal. After receiving standard-of-care treatment (surgery followed by radiation and chemotherapy), fewer than half ...
Dec 12, 2025
0
0
A rare case of rabies linked to an organ transplant has resulted in two deaths, federal health officials announced.
Dec 8, 2025
0
0
A Medicare pilot program will allow private companies to use artificial intelligence to review older Americans' requests for certain medical care—and will reward the companies when they deny it.
Dec 11, 2025
0
0
Adolescent and young adult nicotine vaping has become an urgent public health concern, as 2024 marked the first year that nicotine vaping was the most initiated drug. Though vaping is the most common way young people use ...
Dec 12, 2025
0
0
Researchers at the University of Gothenburg can now demonstrate previously unexplained processes behind growth therapy. It involves hormonal mechanisms at the cellular level, with focus on a sensitive balance between stem ...
Dec 9, 2025
0
0
Daily scans taken during prostate cancer radiotherapy could be repurposed to guide changes to treatment, reducing the risk of side effects, a study suggests.
Dec 11, 2025
0
0
The tiny opaque tube that Yonghui Ding holds up to the light in his laboratory looks like a bit of debris from a dismantled ballpoint pen.
Dec 9, 2025
0
0
The chimeric antigen receptor (CAR) T cell therapy anitocabtagene autoleucel (anito-cel) continued to show strong results in treating relapsed/refractory multiple myeloma, according to new trial data from researchers at The ...
Dec 8, 2025
0
0
